Back to Duquesne Family Office LLC Duquesne Family Office LLC

BEAM

2 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in Beam Therapeutics Inc.

Yes. Duquesne Family Office holds 699,700 shares of BEAM (Beam Therapeutics), worth $17.1M, as of its Q3 2026 13F filing. It increased the position from 153,600 shares in Q2 2026. Duquesne Family Office has held BEAM since Q2 2026, across 2 quarterly 13F filings. BEAM is 0.4% of Duquesne Family Office's reported 13F portfolio.

Current Value

$17.1M

Current Shares

699,700

Total Value Change

+$11.8M

Total Shares Change

+546,100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
699,700
+355.5%
$17.1M0.4%$24.45
54
2026-Q2
New
153,600
-
$5.3M0.1%$34.32
45

Other major holders of BEAM: FMR LLC, ARK Investment Management LLC

Optional analytics helps us improve. How it’s used